Skip to Content

Green Thumb Industries Inc GTII

Morningstar Rating
CAD 16.66 −0.07 (0.42%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Cannabis Shares Rally (Again) on Next Incremental Step to Federal Rescheduling

Shares of Canadian-licensed producers and US multistate operators rallied massively on news that the US Drug Enforcement Administration will proceed with rescheduling cannabis to Schedule III from Schedule I. Schedule I indicates it is considered to have a high potential for abuse and no medical value. In comparison, Schedule III drugs are considered less dangerous, with a lower potential for abuse and having some medical value. We view the April 30 news as the next step in a long process by the Biden administration to relax the current federal prohibition. We view the market reaction as a reflection of how much pressure these stocks have faced rather than any new development.

Price vs Fair Value

GTII is trading at a 48% discount.
Price
CAD 16.73
Fair Value
CAD 43.00
Uncertainty
Very High
1-Star Price
CAD 53.00
5-Star Price
CAD 12.00
Economic Moat
Nsqzy
Capital Allocation
Vgbmzgdlgk

Bulls Say, Bears Say

Bulls

Green Thumb gives investors pure-play exposure to the U.S., which we forecast will be the largest market in the world by sales.

Bears

States are incentivized to maximize tax revenue for products like alcohol, tobacco, and cannabis. Although alcohol and tobacco companies successfully pass higher taxes onto consumers, cannabis companies lack the brand power to do the same.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GTII is a good fit for your portfolio.

News

Trading Information

Previous Close Price
CAD 16.73
Day Range
CAD 16.6617.86
52-Week Range
CAD 8.6221.50
Bid/Ask
CAD 16.64 / CAD 16.80
Market Cap
CAD 3.93 Bil
Volume/Avg
213,014 / 170,704

Key Statistics

Price/Earnings (Normalized)
43.77
Price/Sales
2.81
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
1.37%

Company Profile

Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates 92 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
4,561

Competitors

Valuation

Metric
GTII
CURLF
TLRY
Price/Earnings (Normalized)
43.77
Price/Book Value
1.753.730.46
Price/Sales
2.812.871.90
Price/Cash Flow
11.4167.72
Price/Earnings
GTII
CURLF
TLRY

Financial Strength

Metric
GTII
CURLF
TLRY
Quick Ratio
1.620.310.96
Current Ratio
2.720.851.92
Interest Coverage
8.83−0.24−4.39
Quick Ratio
GTII
CURLF
TLRY

Profitability

Metric
GTII
CURLF
TLRY
Return on Assets (Normalized)
3.06%−3.72%−1.42%
Return on Equity (Normalized)
4.55%−10.45%−1.82%
Return on Invested Capital (Normalized)
3.80%−2.20%−0.92%
Return on Assets
GTII
CURLF
TLRY
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AWgkjzgcwPxhql$76.9 Bil
MKKGY
Merck KGaA ADRLgfwzmxxwfJswglmm$71.9 Bil
HLN
Haleon PLC ADRTlwrbmplZhb$37.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRPjykkmgcmJtgy$15.6 Bil
VTRS
Viatris IncVqntmrnvTpfc$14.0 Bil
RDY
Dr Reddy's Laboratories Ltd ADRCtpcbknGmbw$12.5 Bil
CTLT
Catalent IncPwxxczfhTbwqz$10.2 Bil
PRGO
Perrigo Co PLCMczbzdgtFwxcw$4.1 Bil
CURLF
Curaleaf Holdings IncGldmxfbqShybx$3.9 Bil
PBH
Prestige Consumer Healthcare IncNjjcspmnFpwhd$3.5 Bil

Sponsor Center